Lataa...
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
Conventional treatment approaches have had little impact on the course of pancreatic cancer, which has the highest fatality rate among cancers. Gemcitabine, the primary therapeutic agent for pancreatic carcinoma, produces minimal survival benefit as a single agent. Therefore, numerous efforts have f...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3482496/ https://ncbi.nlm.nih.gov/pubmed/21402145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.freeradbiomed.2011.03.007 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|